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Objective: To analyze the ovarian reserve via measurement of follicular density and 
anti-Müllerian hormone (AMH) in endometriosis patients participating to a clinical pro-
gram of cortical ovarian cryopreservation.
Design: Retrospective analysis of serum AMH levels and prospective investigation of 
ovarian follicle number.
setting: University Hospital.
Patient(s): Two hundred and two women with endometriosis and 400 controls.
intervention(s): Blood samples and ovarian biopsies.
Main outcome measure(s): Correlation of serum AMH levels and the number of 
non-growing follicles in the biopsied cortical tissues in endometriosis and control sub-
jects, including age, type of AMH kit, and the laboratory performing the analysis as 
covariates.
result(s): AMH levels were shown to decrease with age in untreated endometriosis 
patients (P < 1.0 × 10−5) but they were significantly lower in endometriosis compared 
to controls only in patients over 36 years old (P = 2.7 × 10−4). The AMH decrease was 
faster in endometriosis compared to controls (beta = 0.27, P = 4.0 × 10−4). Primordial 
follicle number decreased with the reduction of AMH levels in both cases and controls 
(beta = 0.3; P = 0.04).
conclusion: AMH is a reliable marker of ovarian reserve in endometriosis patients, and 
it can predict follicular density in women undergoing ovarian tissue cryopreservation.
Keywords: ovarian reserve, anti-Müllerian hormone, follicle density, ovarian tissue cryopreservation, fertility 
preservation
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inTrODUcTiOn
Fertility preservation represents a significant clinical challenge 
for the biomedical community. Initially developed for onco-
logical patients (1), approaches to fertility preservation have 
been extended to women at risk to develop premature ovarian 
insufficiency (POI) as a consequence of genetic or environmental 
causes and/or gynecological treatments (2).
Available options for fertility preservation for adult women 
include the cryopreservation of oocytes, which, thanks to the devel-
opment of vitrification protocols, allows the achievement of fertiliza-
tion rates comparable to those with fresh gametes (3, 4). However, 
this approach cannot be applied to young women who have not yet 
reached sexual and psychological maturity, to patients who need to 
start an immediate anticancer treatment, or to women with hormone-
sensitive malignancies. In these cases, cryopreservation of the ovarian 
cortical tissue could be proposed (5). Although about 60 babies were 
born so far after ovarian tissue transplantation (6), this method is 
still considered an experimental technique. Yet, new technologies 
for in vitro maturation of oocytes collected from the ovarian cortex 
during laparoscopic surgery have recently opened new horizons (7). 
However, low follicular density may limit the success of the fertility 
restoration and the identification of presurgical reliable markers of 
ovarian follicle density could help to avoid useless surgeries and, at the 
same time, give indications of the optimal age for tissue collection. To 
date, the most used non-invasive tests are the ovarian antral follicle 
count (AFC), evaluated by ultrasound, and serum anti-Müllerian 
hormone (AMH) (8) both considered predictive in assisted repro-
ductive treatment (ART) or for age of menopause (9, 10).
Among the many iatrogenic and pathological conditions that 
compromise ovarian function, endometriosis, a sterile inflammatory 
disease characterized by growth of endometrial tissue at ectopic loca-
tion, may represent a cause of early menopause, as indicated by its asso-
ciation with infertility in more than 50% of affected patients (11, 12). 
The chronic clinical course of endometriosis, associated with its 
common bilateral involvement, and the frequently repeated surgical 
interventions suggest that ovarian cryopreservation might represent 
a promising option for fertility preservation in affected women.
The primary goal of this study was to evaluate presurgical 
serum AMH levels in a cohort of endometriosis patients under-
going ovarian cortex resections for fertility preservation at our 
institution in the years 2011–2014, compared to a large control 
group, and then to test the hypothesis that the preoperative AMH 
values correlated with the individual follicular density.
To our knowledge, this is the first study that analyzed ovarian 
reserve through combined measurement of follicular density 
and serum AMH levels in the same endometriosis subjects. Even 
though a limited sample size was analyzed, we showed that AMH 
might be used as a marker of ovarian reserve in endometriosis 
cases.
MaTerials anD MeThODs
human subjects
Two hundred and two women with endometriosis undergo-
ing surgery for the first time were included in the study. The 
majority (156; 77.2%) presented with ovarian endometriosis, of 
which 35 (22.4%) had bilateral and 121 (77.6%) had unilateral 
endometriosis. All patients were in premenopausal period, with 
a mean age of 34.7 ±  5.9  years (19–48 age range). The AMH 
dosage was performed the day before surgery. Ovarian biopsies 
were collected from a subgroup of 25 patients at the beginning of 
the surgery to avoid thermal, vascular, chemical, and mechanical 
damage of the ovaries. Biopsies were collected with microscis-
sors with cold blade from healthy ovarian cortex, either from the 
non-affected ovary or, in cases of bilateral disease, far from the 
cyst. Tissue samples of about 4 mm × 4 mm were transferred to 
the pathology laboratory in formaldehyde. For histochemistry 
analysis, samples were randomly collected far from the affected 
site, as a previous study reported that ovarian biopsies sampled 
at random show an error of 0.5% in estimating the non-growing 
follicles (13).
Control biopsies were taken from 33 patients undergoing 
surgery for causes different from endometriosis. Indications for 
surgery were uterine leiomyomas with menorrhagia (n =  14), 
ovarian cryopreservation for extra-gynecological oncologic 
reasons (n = 4), infertility due to tube obstruction (n = 7), and 
non-endometriotic cysts (n = 8).
Controls for serum AMH levels were subjects from two dif-
ferent populations of premenopausal women all of Italian origin. 
They included 200 women randomly selected from the Italian 
Network of Genetic Isolates/Val Borbera population (14), a nor-
mal population of North West Italy, and 200 randomly selected 
women from a cohort undergoing ART for male infertility at the 
Obstetrics and Gynecology Unit, San Raffaele Scientific Institute.
The study including the overall plan and the informed consent 
form was reviewed and approved by the institutional review 
boards of the San Raffaele Scientific Institute.
Tissue Preparation and Follicle counts
During the paraffin wax embedding, each ovarian biopsy was 
marked by Indian ink on the inner part in order to obtain a right 
orientation from ovarian surface to deep cortex. Paraffin block 
was then cut perpendicularly to ovarian surface into 5-μm sec-
tions, at 50-µm intervals to avoid the overcounting of the same 
follicle (primordial and primitive follicles do not exceed this 
size). Sections were then stained with hematoxylin and eosin. All 
sections were analyzed using an Olympus microscope at 200× 
magnification. The developmental stages of follicles were defined 
according to Gougeon’s protocol (1986), which defines that the 
primordial follicle is a structure containing the primary oocyte 
surrounded by a single flat cells stratum, while the primitive fol-
licle is an element assembled by the primary oocyte surrounded 
by the zona pellucida and by 1–2 cubical cells of the granulosa 
tissue (Figures  1A,B). The follicle density was determined by 
dividing the number of follicles counted in 10 non-adjacent fields 
of 1 mm2 each by the volume of tissue analyzed (0.5 mm3) and 
expressed as number of follicles per mm3.
hormone assay
Serum AMH levels were measured in cases and in the two control 
cohorts in the course of several years by two types of commercially 
FigUre 1 | Histological analysis of cortical ovarian strips. (a) Hematoxylin/
eosin staining shows primordial, early, and mature primary follicles of one 
representative ovarian cortical strip of a control (125×). (B) Hematoxylin/eosin 
staining shows a few primordial follicles (severe ipotrophia for age of the 
patient) in a fibrosclerotic tonaca albuginea of one representative cortical strip 
of an endometriosis patient (200×).
TaBle 1 | Serum AMH concentrations in cases and controls.
number age (years)a aMh (ng/ml)a
Cases 201 34.72 ± 5.93 1.786 ± 1.87
Controls 387 35.30 ± 6.36 2.928 ± 2.28
aMean ± SD.
AMH, anti-Müllerian hormone.
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available immunoenzymatic assays: the GenII ELISA (Beckman 
Coulter) and the EIA AMH/MHS kit (Immunotech, Beckman 
Coulter). The limit of detection (LOD) of both assays was 0.14 ng/ml. 
For participants with measurements below the LOD, values were 
replaced with LOD/√2 (15). AMH was detected in 8% of cases 
and 2.5% of controls. Intra-assay and inter-assay coefficients of 
variation were 12.3 and 14.2%, respectively.
statistical analysis
In-house R 3.1.1 scripts (http://www.r-project.org) were used 
for descriptive and inferential statistics analyses of follicles 
counts and the levels of AMH in the total sample (N =  602). 
For each measurement, outlier values were excluded using a 3 
SD threshold based on Shapiro–Wilk normality tests assessing 
the normality of the distributions. After outliers exclusion, 
we analyzed 588 AMH (201 cases and 387 controls) and 57 
follicle counts (24 cases and 33 controls). Then, follicle counts 
were square root transformed to normalize. AMH dosage was 
transformed with a rank-based inverse normalization using the 
quantile R function qnorm (p, μ, σ) that converts proportions 
to quantiles. The continuous distributions of each transformed 
trait were represented by density() R function. The R wilcox.
test() function and/or t.test() function were used to estimate 
significant difference in the median and/or mean of case/con-
trol population and in young and old (≤36 and >36 years old). 
The glm() R function was used to fit generalized linear models in 
regression analyses, and ggplot2 library was used for exploratory 
data analysis and plotting results.
resUlTs
aMh levels Were Progressively reduced 
with age in Untreated endometriosis 
Patients
Serum AMH values of 201 untreated endometriosis patients and 
387 normal women were included in the analysis. The mean of 
AMH level was lower in cases compared to controls (Table 1). 
Since AMH levels were measured using two different kits by two 
independent laboratories, we tested the statistical dependence 
of AMH and the two confounding factors, kit and laboratory, 
in addition to age. All variables showed significant correlations 
(P < 1.0 × 10−5) assessed using the Spearman’s rank correlation 
test, and were therefore included as covariates in all the analyses. 
Regression analysis, after the exclusion of the confounding effect 
of the whole set of covariates, showed that the median of the AMH 
residual levels was significantly lower in cases [median = −0.17 
(−1.97 to 2.99)] compared to controls [median = 0.06 (−3.03 to 
2.67)] (P = 1.0 × 10−3).
It has been estimated that women older than 36 years present 
a significant depletion of the ovarian reserve (16, 17). When the 
threshold of 36 years of age was used to subdivide the population 
in two groups, only >36 year-old cases had a significant decrease 
in AMH residual levels compared to controls: cases median 
of residues = −0.87 (−1.82 to 2.58) versus controls median of 
residues = −0.25 (−2.30 to 2.57) (P = 2.7 × 10−4).
To better describe the decrease of AMH levels with age in 
endometriosis patients, we performed a multiple regression 
analysis of AMH and age including all the above covariates. 
Serum AMH levels decreased with increasing age in patients and 
in controls as expected, but the decrease was faster in endome-
triosis cases (Figure  2). To conclude that the effect of age was 
different in cases and controls, the interaction between age and 
affection status was included in the analysis: the interaction was 
highly significant (beta = 0.27, P = 4.0 × 10−4). The faster decrease 
of the AMH residual levels with age was further confirmed when 
either considering all ovarian endometriosis cases (n = 155), or 
separating bilateral (n = 35) from unilateral (n = 120) cases (data 
not shown).
TaBle 2 | Primordial and primary follicle counts from ovarian biopsies in cases 
and controls.
number Primordiala Primarya
Cases 24 12.25 ± 16.48 7.9 ± 7.35
Controls 33 14.42 ± 18.36 10.42 ± 12.16
aMean ± SD.
FigUre 2 | Multiple regression analysis of anti-Müllerian hormone (AMH) and age. AMH kit and laboratory were included as covariates. Scatter plot of the 
correlation between AMH residues and age in cases (solid circles) and controls (solid triangles). Linear interpolation for cases (solid lines) and controls (dashed lines) 
together with confidence intervals (gray shadowed area) are reported.
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Primordial Follicle counts correlated with 
the Decrease in aMh levels in Both  
cases and controls
Ovarian biopsies were performed in a subset of 24 endometriosis 
cases and 33 controls (Table 2). Counts of primordial follicles 
did not show significant differences between cases and controls. 
Primordial follicle numbers were slightly lower in endometrio-
sis cases but the difference was not statistically significant even 
if only older cases (>36 years) were considered. As expected, 
the follicle number decreased with age both in endometriosis 
cases and controls (beta = −0.19; P = 2.15 × 10−5).
To test our primary hypothesis, that a correlation between 
AMH levels and follicle numbers could be established in 
endometriosis patients, we performed a regression analysis of 
AMH and follicle numbers including age and kit/laboratory as 
covariates, as discussed above. Considering the entire dataset, 
including the endometriosis patients, a statistically significant 
correlation was observed between AMH residual levels and 
the numbers of primordial follicles (beta  =  0.3; P  =  0.04): 
lower AMH residual levels corresponded to lower numbers of 
primordial follicles. The beta of the regression curve was higher 
in cases, suggesting a faster depletion of primordial follicles in 
endometriosis patients (Table S1 in Supplementary Material); 
however, due to the small number of individuals available when 
the controls were analyzed separately or affection status was 
included in the analysis, the regression was not statistically 
significant.
DiscUssiOn
In the last 10  years, oocyte and ovarian cortical tissue cryo-
preservation have become valuable options to restore fertility and 
improve quality of life of patients with early menopause. Ovarian 
cryopreservation, which represents the only choice for prepuberal 
patients (5), is strictly dependent on the presence of an adequate 
number of follicles in the surgically removed cortical ovarian 
strips. As this cannot be merely predicted from the chronological 
age, presurgical ovarian reserve tests are dearly needed to avoid 
useless surgery (18).
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Anti-Müllerian hormone is the best available marker of 
ovarian reserve and an indicator of response to gonadotropin 
stimulation (9). Despite its variability, the threshold value of 
1.28  ng/ml, identified as an indicator of sufficient immature 
oocyte yield (19), is currently used in in vitro fertilization. It has 
been shown repeatedly that AMH levels decrease in endome-
triosis patients after surgery (20, 21), but only small studies have 
been published on presurgical serum AMH level, in patients of 
Asian origin to determine whether AMH is a reliable marker 
also for endometriosis-associated infertility and it could be used 
to predict follicular density for fertility preservation.
We here report a study of AMH levels and ovarian reserve in 
201 untreated endometriosis patients of Italian origin undergoing 
surgery for the first time. The results showed that AMH levels 
before surgery were significantly lower in endometriosis cases 
compared to controls (P = 1.0 × 10−3), in agreement with a similar 
analysis in a cohort of patients from Korea (22). Interestingly, by 
splitting our cohort into two different age groups, we showed that 
AMH levels might account for a difference between cases and 
controls only in women older than 36 years. When we analyzed 
older patients separately from younger patients, we showed that 
only in older women the mean value of AMH levels were signifi-
cantly different in cases and controls (P = 2.7 × 10−4). Accordingly, 
serum AMH levels decreased faster with increasing age in endo-
metriosis cases compared to controls. The difference between 
cases and controls was statistically significant (P = 4.0 × 10−4). 
The endometriosis localization did not seem to influence the 
observed faster decrease of the ovarian reserve in endometriosis 
patients, suggesting that it may be the general inflammation 
status, free radicals, hyperoxidation, and iron deposits or the 
genetic alterations that predispose to endometriosis to influence 
the ovarian reserve and possibly also worsen follicle quality in 
endometriosis (23).
Anti-Müllerian hormone levels and ovarian follicle numbers 
have been shown to correlate in previous studies. We now show 
that they appear directly correlated also in our study of endome-
triosis patients. Despite the small number of individuals available, 
we could correlate the number of primordial follicles and the 
AMH levels in the same individual, giving our study a greater 
sensitivity than similar studies (10). The numbers of primordial 
and primary follicles were slightly lower but not significantly 
different in endometriosis cases, and the comparison between 
young (≤36 years) and older (>36 years) women did not change 
the results. Interestingly, by analysis of the entire dataset, we sig-
nificantly associated AMH levels with the number of primordial 
follicles (beta =  0.3; P =  0.04): as expected, lower AMH level 
corresponded to a lower number of primordial follicles. When 
the affection status was included in the analysis, the difference 
between cases and controls was not statistically significant 
(beta = −0.05; P = 0.87). The lack of significance could be due to 
the small number of individual pieces of ovarian cortex studied 
so far, as it is well known that follicle density may vary through 
the whole ovarian cortex (24). Indeed, analysis of larger dataset 
could add more power and demonstrate even small differences. 
It is interesting to note here that, when cases and controls were 
analyzed separately, the effect (beta) of the AMH level on the 
number of primordial follicles was higher in cases compared to 
controls. This suggests a faster decline of the number of primor-
dial follicles associated with a faster decrease of AMH levels, and 
thus a direct effect of endometriosis on ovarian reserve.
The analysis of a larger cohort of patients could definitively add 
significance to the study, although our data already indicate that 
AMH represents a reliable marker of ovarian reserve in untreated 
endometriosis patients. Importantly, our study shows that AMH 
levels should be evaluated early during disease progression, to 
take into account the accelerated follicular depletion, and thus 
justify ovarian cryopreservation.
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